MARKET INTRODUCTION
Neuraminidase Inhibitor are the class of drugs which inhibits viral neuraminidase enzyme. The neuraminidase inhibitors are mainly utilized as an antiviral drugs especially against influenza virus. It is effective against both type A and type B influenza virus. The Neuraminidase inhibitors inhibit viral neuraminidases and prevents virus replication from the host cell. Commonly used NAIs are zanamivir, Oseltamivir etc.
MARKET DYNAMICS
The key market drivers for Neuraminidase Inhibitor Market Includes, rising incidences of influenza A and influenza B virus cases, rising demand for antiviral drugs, ongoing clinical trials for antiviral drugs are some of the factors which are expected to drive the market growth during the forecast period. However, stringent FDA guidelines and possible side effects from drugs are expected to restrain market growth during the forecast period.
MARKET SCOPE
The "Neuraminidase Inhibitor Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Neuraminidase Inhibitor market with detailed market segmentation by indication, drug type, and route of administration and distribution channel. The Neuraminidase Inhibitor Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Neuraminidase Inhibitor Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Neuraminidase Inhibitor Market is segmented on the basis of indication, drug type, and route of administration and distribution channel. On the basis of indication the market is segmented as, influenza virus A, influenza virus B and others. On the basis of drug type the market is segmented as, zanamivir, oseltamivir, peramivir and others. And on basis of distribution channel, hospital pharmacy, retail pharmacy and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Neuraminidase Inhibitor Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Neuraminidase Inhibitor Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Neuraminidase Inhibitor Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Neuraminidase Inhibitor Market in these regions.
MARKET PLAYERS
The report covers key developments in the Neuraminidase Inhibitor Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Neuraminidase Inhibitor Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Neuraminidase Inhibitor market in the global market. Below mentioned is the list of few companies engaged in the Neuraminidase Inhibitor Market.
The report also includes the profiles of key players in Neuraminidase Inhibitor Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Strides Consumer LLC
- BioCryst Pharmaceuticals, Inc
- Teva Pharmaceuticals Industries, Ltd
- NATCO Pharma Limited
- Alvogen
- Amneal Pharmaceuticals, LLC
- Macleods Pharmaceuticals, Ltd
- F. Hoffmann-La Roche Ltd
- GlaxoSmithKline Plc
- Lupin
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.